A global view of the interplay between non-alcoholic fatty liver disease and diabetes
出版年份 2022 全文链接
标题
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
作者
关键词
-
出版物
Lancet Diabetes & Endocrinology
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-02-18
DOI
10.1016/s2213-8587(22)00003-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial
- (2021) Anat Yaskolka Meir et al. GUT
- Identifying subgroups of people at risk for type 2 diabetes
- (2021) Miriam S. Udler NATURE MEDICINE
- Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
- (2021) Robert Wagner et al. NATURE MEDICINE
- Global pandemics interconnected — obesity, impaired metabolic health and COVID-19
- (2021) Norbert Stefan et al. Nature Reviews Endocrinology
- COVID-19 and liver disease: mechanistic and clinical perspectives
- (2021) Thomas Marjot et al. Nature Reviews Gastroenterology & Hepatology
- Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records
- (2021) Jonathan Pearson-Stuttard et al. Lancet Diabetes & Endocrinology
- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- Liver-targeting drugs and their effect on blood glucose and hepatic lipids
- (2021) Amalia Gastaldelli et al. DIABETOLOGIA
- Increased adipose tissue fibrogenesis, not impaired expandability, is associated with nonalcoholic fatty liver disease
- (2021) Joseph W. Beals et al. HEPATOLOGY
- The mitochondrial dicarboxylate carrier prevents hepatic lipotoxicity by inhibiting white adipocyte lipolysis
- (2021) Yu A. An et al. JOURNAL OF HEPATOLOGY
- Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort
- (2021) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments
- (2021) Giovanni Targher et al. Nature Reviews Gastroenterology & Hepatology
- Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
- (2021) Giovanni Targher et al. Lancet Gastroenterology & Hepatology
- Hyperglycemia in Acute COVID-19 is Characterized by Insulin Resistance and Adipose Tissue Infectivity by SARS-CoV-2
- (2021) Moritz Reiterer et al. Cell Metabolism
- Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement
- (2021) Jerome Boursier et al. DIABETES & METABOLISM
- Preparing for the NASH Epidemic: A Call to Action
- (2021) Fasiha Kanwal et al. DIABETES CARE
- Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial
- (2021) Giuseppe Della Pepa et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
- (2021) Fasiha Kanwal et al. GASTROENTEROLOGY
- The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD
- (2021) Chandani Patel Chavez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
- (2021) Bernhard Ludvik et al. LANCET
- PPAR‐γ‐induced Changes in Visceral Fat and Adiponectin Levels are Associated with Improvement of Steatohepatitis in Patients with NASH
- (2021) Amalia Gastaldelli et al. LIVER INTERNATIONAL
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease
- (2021) Diana Barb et al. Obesity
- Treatment of type 2 diabetes: challenges, hopes, and anticipated successes
- (2021) Michael A Nauck et al. Lancet Diabetes & Endocrinology
- Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study
- (2021) Min Gao et al. Lancet Diabetes & Endocrinology
- Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
- (2021) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Possible Involvement of Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19
- (2021) Jihoon Shin et al. DIABETES
- Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis
- (2021) Ali Aminian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells
- (2021) Mario Witkowski et al. NATURE
- Lipodystrophic Nonalcoholic Fatty Liver Disease Induced by Immune Checkpoint Blockade
- (2020) Thomas Eigentler et al. ANNALS OF INTERNAL MEDICINE
- Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
- (2020) Stefano Romeo et al. Cell Metabolism
- Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes
- (2020) Kenneth Cusi DIABETES CARE
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of Nonalcoholic Fatty Liver Disease
- (2020) James M. Paik et al. HEPATOLOGY
- Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores
- (2020) Giovanni Targher et al. GUT
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate
- (2020) Steven Zhao et al. NATURE
- Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
- (2020) Robert F. Kushner et al. Obesity
- Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies
- (2020) Helen Jarvis et al. PLOS MEDICINE
- Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience
- (2020) Ioan Sporea et al. Journal of Clinical Medicine
- Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
- (2020) Tran Thi Khanh Tuong et al. Diagnostics
- Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
- (2020) Ana Campos Codo et al. Cell Metabolism
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- Causes, consequences, and treatment of metabolically unhealthy fat distribution
- (2020) Norbert Stefan Lancet Diabetes & Endocrinology
- Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
- (2020) Juan Pablo Arab et al. Annals of Hepatology
- Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
- (2020) Tracey G Simon et al. GUT
- Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
- (2020) Alessandro Mantovani et al. GUT
- Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
- (2020) Sven Francque et al. Nature Reviews Gastroenterology & Hepatology
- Cardiovascular risk in patients with nonalcoholic fatty liver disease: looking at the liver to shield the heart
- (2020) Kenneth Cusi et al. CURRENT OPINION IN LIPIDOLOGY
- High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes
- (2020) Stefano Ciardullo et al. DIABETES CARE
- Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease
- (2020) Kasper W. ter Horst et al. DIABETES CARE
- Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
- (2020) Romina Lomonaco et al. DIABETES CARE
- The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
- (2020) Thinzar Min et al. Diabetes Therapy
- Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
- (2020) Manu V. Chakravarthy et al. Frontiers in Endocrinology
- The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2020) Dimitrios A. Koutoukidis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gut microbial metabolites in obesity, NAFLD and T2DM
- (2019) Emanuel E. Canfora et al. Nature Reviews Endocrinology
- Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program
- (2019) Yvonne Huber et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effects of a Mediterranean Eating Plan on the Need for Glucose-Lowering Medications in Participants With Type 2 Diabetes: A Subgroup Analysis of the PREDIMED Trial
- (2019) F. Javier Basterra-Gortari et al. DIABETES CARE
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- Diabetes is Associated with Increased Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
- (2019) Ju Dong Yang et al. HEPATOLOGY
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- A Mediterranean Diet Rich in Extra-Virgin Olive Oil Is Associated with a Reduced Prevalence of Nonalcoholic Fatty Liver Disease in Older Individuals at High Cardiovascular Risk
- (2019) Xavier Pintó et al. JOURNAL OF NUTRITION
- Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement
- (2019) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- NAFLD in children: new genes, new diagnostic modalities and new drugs
- (2019) Valerio Nobili et al. Nature Reviews Gastroenterology & Hepatology
- Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study
- (2019) Oana P Zaharia et al. Lancet Diabetes & Endocrinology
- Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
- (2019) Ian J Neeland et al. Lancet Diabetes & Endocrinology
- Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels
- (2019) Samer Gawrieh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Metabolically healthy obesity: facts and fantasies
- (2019) Gordon I. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Clusters provide a better holistic view of type 2 diabetes than simple clinical features
- (2019) Emma Ahlqvist et al. Lancet Diabetes & Endocrinology
- Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes
- (2019) A. Mantovani et al. DIABETES & METABOLISM
- Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Non‐alcoholic Fatty Liver Disease
- (2019) Fasiha Kanwal et al. HEPATOLOGY
- The double burden of malnutrition: aetiological pathways and consequences for health
- (2019) Jonathan C Wells et al. LANCET
- The integrative biology of type 2 diabetes
- (2019) Michael Roden et al. NATURE
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis
- (2018) Marina Kawaguchi-Suzuki et al. Frontiers in Pharmacology
- Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
- (2018) Jonathan Pearson-Stuttard et al. Lancet Diabetes & Endocrinology
- Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
- (2018) Emma Ahlqvist et al. Lancet Diabetes & Endocrinology
- Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection
- (2018) Sue Tsai et al. Cell Metabolism
- Dietary Sugars Stimulate Fatty Acid Synthesis in Adults
- (2018) Elizabeth J. Parks et al. JOURNAL OF NUTRITION
- Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
- (2018) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK
- (2018) Krishnan Bhaskaran et al. Lancet Diabetes & Endocrinology
- Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals
- (2017) Bo Kobberø Lauridsen et al. EUROPEAN HEART JOURNAL
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
- (2017) Leon A Adams et al. GUT
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Liver fibrosis scores predict liver disease mortality in the United States population
- (2017) Aynur Unalp-Arida et al. HEPATOLOGY
- Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease
- (2017) Fernando Bril et al. HEPATOLOGY
- The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups
- (2017) Shiv Chitturi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment
- (2017) Vincent Wai-Sun Wong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Emmanuela Gakidou et al. LANCET
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Theo Vos et al. LANCET
- Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci
- (2017) Stefan Stender et al. NATURE GENETICS
- Exome-wide association study of plasma lipids in >300,000 individuals
- (2017) Dajiang J Liu et al. NATURE GENETICS
- Mechanisms, Pathophysiology, and Management of Obesity
- (2017) Steven B. Heymsfield et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Efficacy and Safety of Liraglutide 3.0 mg in Individuals with BMI above and below 35 kg/m²: A Post-hoc Analysis
- (2017) Carel le Roux et al. Obesity Facts
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
- (2016) Romina Lomonaco et al. DIABETES CARE
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) et al. DIABETOLOGIA
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis
- (2016) Mark A. Herman et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications
- (2016) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Phenotypes of prediabetes and stratification of cardiometabolic risk
- (2016) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
- (2015) Zobair M. Younossi et al. HEPATOLOGY
- Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids
- (2015) Daniel F. Vatner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- (2013) Jennifer E. Lambert et al. GASTROENTEROLOGY
- In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not
- (2012) Zobair M. Younossi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liver, Muscle, and Adipose Tissue Insulin Action Is Directly Related to Intrahepatic Triglyceride Content in Obese Subjects
- (2008) Kevin M. Korenblat et al. GASTROENTEROLOGY
- A pilot study of the effects of pioglitazone and rosiglitazone on de novo lipogenesis in type 2 diabetes
- (2008) Carine Beysen et al. JOURNAL OF LIPID RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started